Market-Leading Visual Storytellers

We support Biotechs and Pharma
at every stage of the life cycle

PRECLINICAL

DEVELOPMENT

CLINICAL DEVELOPMENT

Phase 1  |  Phase 2  |  Phase 3

LAUNCH /
POST LAUNCH

 

BRAND MATURITY
Phase 4

 

 

Trusted by Top-20 Pharma and 100+ small and medium Biotechs

High Science. Tech-Enabled

Strategy

Content

Digital + Social

Most Tech-enabled

We are pioneering innovative solutions fueled by proprietary
technologies, top tech, science and creative talent

  • MoD/MoA animation
    and illustration

  • Bespoke presentations 

  • Field content resources

  • Congress booth programs

  • Websites

  • 75% of routine steps are automated using proprietary software and machine learning.

  • The most efficient production pipeline with 3x faster delivery.

  • Data-driven feedback loop optimization for every asset.

 

  • Live strategy workshops

  • Scientific communications
    platform (ScP), lexicon

  • Content optimization
    and channel planning

  • Microcontent planning
    and development:

  • Custom apps

  • Veeva-trained staff

  • Animated data

  • 15-second videos

  • Visual digests

All fueled by the most advanced production pipeline in the industry

Precision backed by top voices:

Education & Impact: 500M+ views

and 100+ more

6 animation types 

and 20 subtypes for every need — audience, company stage and budget.

INCLUDING TWO UNIQUE

High-End 3D
 

The most advanced animation type on the market, based on computational biology methods. Science-grade molecular simulations for unprecedented accuracy.

Read more about the methods we use for this animation type in the whitepaper.

 

 

UNIQUE SCIENTIFIC-GRADE TYPE

High-End 3D
Coronavirus atomic resolution model

Featured:

Read more about the methods we use for this animation type in the whitepaper.

 

 

UNIQUE SCIENTIFIC-GRADE TYPE

High-end 3D
HIV Atomic Resolution Model

Featured:

Awarded:

UNIQUE SCIENTIFIC-GRADE TYPE

Main 3D

Main 3D is the most universal animation type. It's scientifically rigorous, eye-catching, and very cinematic. It's a great match for most MoAs and MoDs for IR needs, alongside HCP communications.

Main 3D + 2D

 

The usual Main 3D animation type in combination with 2D elements. This is an excellent option for MoAs where there's a need to incorporate research data, schematics, or other additional information.

UNIQUE APPROACH

2D Animation

For Nature Journal

A relatively simple, yet still eye-catching 2D animation style is an ideal option for explainer animations, platform or AI-based technologies, alongside cases where IP details must not be disclosed.

2D Animation:

For HCP and Patient Education
 

2D Animation:

For HCP and Patient Education
 

Clear, simple, a eye-catching 2D animation style is an ideal option
for explainer animations, HCP and patient education videos

Deck3D
 

This type is designed specifically for projects with tight deadlines. Through optimization, we achieve a rapid turnaround without compromising quality or scientific accuracy. The fastest type of 3D animation to produce on the market. 

UNIQUE

Pathway3D

Scientific-grade models with the fastest turnaround — delivered in days, not months

A unique combination of scientific-grade molecular simulations that accurately represents real molecular interactions and states, with all the benefits of 2D animation —affordable and fast to produce. Unbeatable quality-to-cost-per-second ratio.  

UNIQUE

Character Animation:

For HCP and Patient Education
 

Clear, simple, a eye-catching 2D animation style is an ideal option
for explainer animations, HCP and patient education videos

Explainer Videos

medical device, procedure, health wearable, and diagnostic companies

Short formats & Chapterized assets 

 

UNIQUE

The Most Tech Enabled

75% of Tasks Automated via Algorithms, Machine Learning, and AI Agents

3D type

High-end 3D

Deck3D

2D type

Pathway3D

+20 subtypes

7-8 weeks

8-10 weeks

4-5 weeks

3-5 weeks

10 days

1-9 weeks

In-House
Studio

STRATEGY

DISCOVERY

DECKS AND INFOGRAPHICS

 

97% of clients rate working with us 9 or 10/10

Atsena Tx. Investor deck

 

Type:
Series B deck

 

Time:

6 weeks

 

Scope:

IR, scientific flow optimization, design, illustrations, animations
 

 

 

 

Hookipa (NAS: HOOK) – Corporate Deck

 

Type:
Corporate deck  for public company

 

Time:

5 weeks

 

Scope:

Scientific flow optimization, design, illustrations, animations
 

 

 

 

Jasper Tx (NASDAQ: JSPR) – Corporate Deck

 

Type:
Corporate deck  for public company

 

Time:

4 weeks

 

Scope:

Design, illustrations, animations
 

 

 

 

3D Infographics and Illustrations

Type:
High-end 3D infographics for deck

 

Time:

1 week

 

 

 

 

 

 

2D Infographics and Illustrations

Type:
2D infographics for deck

 

Time:

1 week

 

 

 

 

 

 

MoA Illustrations for Decks

WEB & APPS

 

97% of clients rate working with us 9 or 10/10

APOGEE Tx: Web-site / MoA / Deck

NASDAQ: APGE

Type:
Corporate website for public company

 

Time:

10 weeks

 

Scope:

Design, development, illustrations, animations
 

 

 

 

Enveric Biosciences Web-site

NASDAQ: ENVB

Type:
Corporate website for public company

 

Time:

9 weeks

 

Scope:

Design, development, illustrations, animations
 

 

 

 

Touch Panels and Interactive Decks

For congress support and in field communications

Chapterized Web App with AI assistant

 

UNIQUE

Augmented Reality 

 

97% of clients rate working with us 9 or 10/10

PosterAR platform

 

UNIQUE

Augmented Reality App
 

SCIENTIFIC PLATFORMS LEXICON DEVELOPMENT

  • A medical strategic team that has developed
    100+ scientific platforms

  • Expertise spanning early pipeline programs
    to blockbuster therapies

Much More Than a "Scientific Platform"

01

A cross-functional strategic exercise
to define the clinical value and scientific
rationale of your molecule

02

A clear and compelling story
scalable for all external audiences

03

An internal asset that expedites
approval of external facing assets
 

Confidential — Not for Public Consumption or Distribution

SCIENTIFIC
PLATFORM

Medical Affairs

Commercial

Regulatory

Clinical Program

IR & Corporate Comm.

Payer/Market Access/HEOR

Scalable from Early to Late-Stage Programs

The overarching story
of your molecule and
the clinical challenge
it solves

NARRATIVE

Breaks down the narrative into 5-6 discrete topics,
such as unmet need, MOA, and clinical
trial results

CONCEPTS

5-8 evidence driven Statements which
support each Concept

STATEMENTS

Hyperlinked and annotated reference that support each statement

EVIDENCE

Identifiable Evidence Gaps Needed to Tell
Full Story of your product

GAPS

Program development:

 

Confidential — Not for Public Consumption or Distribution

Challenge

Scientific Narratives at Scale

CASE STUDY

We partnered with a Top-10 Pharma companies to effectively scale and manage the development of Scientific Narratives for 30+ oncology assets.

Approach

  • Prioritized molecules to streamline development

Results

Highly organized and dedicated team approach maximized extended client time
that ultimately contributed to timely implementation of narratives at scale.

Confidential — Not for Public Consumption or Distribution

  • Key upcoming data releases

  • Unmet Need, Novel MOA

  • Disease State

  • Development Stage

  • Staggered sets based on aforementioned priorities
    to effectively manage large volume/workstreams

  • Assigned specific agency teams per set(s)

  • Created succinct narratives for early-stage assets

  • Created comprehensive ScP's for late-stage assets

Scientific Narratives for 30+ Molecules

Intuitive Platform Design

MS Sharepoint or Veeva Vault

Confidential — Not for Public Consumption or Distribution

Appendix

 

15 years in oncology space 

50+

Collaboration with EHA

  • Clonal hematopoiesis (CHIP): mechanisms and consequences

  • The leukemic Bone Marrow niche and pathogenesis of AML

  • BCL2: genetic alteration and role in lymphoid malignancies

  • Mechanisms of action: CAR-T cells

  • Mechanisms of action: Bispecific Abs

  • Mechanisms of action: small molecules inhibitors

  • The role of epigenetic mechanisms in hematological malignancies

  • Techniques: NGS (TIF: PH)

  • Techniques: qPCR (TIF: PH)

  • Techniques: single cell genetics (TIF: pH)

  • Von Willebrand factor structure and defects

  • AI in hematology: AI-based digital morph. analysis

  • Synthetic patients in clinical trials

  • RBCs: Hb linking and releasing O2

Selected Animations:

Have we piqued your interest? Let's chat.

Takeda_Visual Science | July 29 25

By michael_russo

Takeda_Visual Science | July 29 25

Visual Science is an award-winning biomedical visualization and animation company which brings scientists, software engineers, designers and computer graphics specialists under one roof to produce visual content and graphics that are eye-catching and scientifically rigorous. Since 2007, we’ve helped both Fortune 500 and small companies around the world share cutting-edge ideas using clear, compelling graphics. Our graphics have been featured by leading media outlets and viewed hundreds of millions of times.

  • 126